Analysis of whether Midostaurin is a medical insurance drug and its reimbursement amount

Midostaurin is a multi-target tyrosine kinase inhibitor mainly used to treat patients with acute myeloid leukemia (AML) associated with FLT3 mutations and systemic mastocytosis (SM). Since Midostaurin has not yet been officially launched in China, it cannot be included in the domestic medical insurance system, and there is no clear reimbursement amount for medical insurance. If domestic patients need to use this drug, they must purchase it through regular overseas channels and follow laws, regulations and medical guidance to ensure drug safety.

In overseas markets, the original version of midostaurin is available in European, Indian and Turkish versions, with large price differences. The price of the European version of the original drug is relatively high, usually ranging from 20,000 to more than 120,000 yuan; the price of the Indian version of the original drug is relatively medium, and the price of the Turkish version may be affected by exchange rate fluctuations.患者在选择购买渠道时，应充分了解药品规格、价格及运输途径，确保药品来源正规合法，并在专业医生指导下使用。

In addition to the original drug, there is also a generic version of midostaurin on the Indian market. Its pharmaceutical ingredients are basically the same as the original drug. The specification is 25mg*28 tablets. The latest price is about 9,000 yuan. The price of generic drugs is more affordable than the original drugs and is suitable for patients with limited financial conditions who still need to use the drug. However, whether it is an original drug or a generic drug, it should be used under the guidance of a doctor, and blood and liver and kidney functions should be monitored regularly to ensure efficacy and safety.

Generally speaking, midostaurin has not yet been included in medical insurance in China. Patients need to purchase it through formal overseas channels and pay attention to the source and legality of the drug. Overseas original drugs are more expensive, while generic drugs are relatively cheap but of reliable quality. When using midostaurin, individualized dose adjustment and regular monitoring should be carried out as directed by your doctor to ensure the efficacy and medication safety to the greatest extent. Patients should fully understand the market situation and their own needs before purchasing drugs, and arrange treatment plans reasonably.

Reference materials:https://www.drugs.com/